Le Lézard
Classified in: Health
Subject: SCZ

Philadelphia Nursing Home Abuse Lawyer Brian Murphy Outlines the Dangers of Bed Sores When It Comes to Wrongful Death


PHILADELPHIA, Oct. 29, 2019 /PRNewswire-PRWeb/ -- Bed sores are wounds that occur when a person is left for prolonged periods without being turned or moved. They mostly develop at nursing homes/assisted living facilities/hospitals when residents are unattended in beds or wheelchairs. Bed sores are almost entirely preventable.

Known throughout Philadelphia and in the states of PA & NJ for hospital/care facility/nursing home abuse lawsuits, Attorney Brian P. Murphy regularly litigates cases pertaining to pressure ulcers (bed sore) and wrongful death.

In a recent lawsuit (Docket #BUR-L-002324-17, Superior Court of New Jersey, Burlington County Law Division), Brian discovered that multiple failures at the facility led to the development of the pressure ulcer. Mr. Murphy also discovered that there were efforts within the facility to fraudulently conceal & alter medical records. There had even been instances where staff members had documented that they were providing care to the resident, yet the resident had already been moved out of the nursing home. He was relocated to the hospital during the time of false charting. As a result, the nursing home settled the case.

In addition to wrongful death caused by bed sores or pressure ulcers, Mr. Murphy litigates nursing home lawsuits including, but not limited to, the following:

Nursing Home Abuse Lawyer, Brian P. Murphy, offers Free Consultations to individuals who suspect abuse or neglect. All cases are handled on a contingency fee basis, which means that there are no upfront fees, and you will not be charged until the case settles, at which time Mr. Murphy will be reimbursed for his costs and legal fees.

Contact the Attorney
For more information about dehydration, wrongful death, NJ/PA nursing home neglect lawyer Brian Murphy, or to schedule a free consultation, please contact the attorney.

Press release writing by WebSiteText.com | Proofreading by TheProofreaders.com

 

SOURCE The Law Firm of Brian P. Murphy, PC


These press releases may also interest you

at 03:47
Zest Dental Solutions and The Pathway join forces to elevate continuing education in restorative dentistry.
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
FDA grants Medivir´s MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of Legg-Calvé-Perthes Disease
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...

at 03:16
Enzymatica Interim report Q1/2024: MDR certification opens up great commercial opportunities
First quarter Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...

at 03:03
4 university colleges in Denmark join forces to enhance on-site and remote education for radiographers with Sectra Education Portal
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...

at 03:00
Sentrycs Now Part of the UK National Protective Security Authority Catalog of Security Equipment
Sentrycs, a leading innovator in adaptive counter-drone solutions, is proud to announce its inclusion in the prestigious UK National Protective Security Authority Catalogue of Security Equipment (NPSA CSE).  ...

at 02:22
Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

More news about Health...


News published on and distributed by: